Literature DB >> 17164489

Transcatheter closure of ventriculopulmonary artery communications in staged Fontan procedures.

Tarak Desai1, John Wright, Rami Dhillon, Oliver Stumper.   

Abstract

BACKGROUND: Ventricle-pulmonary artery connections in patients after the Fontan procedure lead to ineffective volume loading and can cause long term problems. In patients with a cavopulmonary shunt anterograde pulmonary blood flow is frequently maintained, but can cause significant volume loading of the heart or complicate the subsequent Fontan procedure.
OBJECTIVE: To evaluate the use of transcatheter closure of a ventricle-pulmonary artery communication in the setting of a cavopulmonary shunt or after the Fontan procedure. PATIENTS AND METHODS: Retrospective study at a tertiary referral centre. Eight patients (age 1.5-18 years, mean 7.8 years). INDICATIONS: cardiac failure or persistent pleural effusions after cavopulmonary shunt (n = 2) or after Fontan (n = 3) and abolishing the volume load of the single ventricle prior to Fontan completion (n = 3).
RESULTS: Devices used: Rashkind Umbrella (n = 1), Amplatzer PDA (n = 7) and Amplatzer ASD (n = 1). One patient required two devices. There were no procedural complications. All 3 patients with prolonged pleural effusions (1 post CP shunt and 2 post Fontan) showed complete resolution between 4 and 10 days after catheter closure. Two patients underwent transcatheter occlusion for progressive ventricular dilatation and cardiac failure. The first patient was post Fontan and showed gradual improvement in ventricular function. The second patient (post CP shunt) was in end stage cardiac failure due to severe AV valve regurgitation. The patient died 48 hours after an uncomplicated procedure due to ventricular failure and electromechanical dissociation (non-procedure-related cardiac death). Three patients underwent catheter closure to off-load the systemic ventricle prior to the Fontan procedure. The device had to be removed prior to release in one patient, due to unsatisfactory position.
CONCLUSIONS: Transcatheter closure of ventricle-pulmonary artery communication is a safe and effective technique in the treatment of selected patients after cavopulmonary shunt or Fontan procedure with early or late complications due to inappropriate pulmonary blood flow. This intervention should also be considered in the preparation for the Fontan procedure in selected patients with ventricular overload.

Entities:  

Mesh:

Year:  2006        PMID: 17164489      PMCID: PMC1861487          DOI: 10.1136/hrt.2006.093757

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  10 in total

1.  Effect of accessory pulmonary blood flow on survival after the bidirectional Glenn procedure.

Authors:  R D Mainwaring; J J Lamberti; K Uzark; R L Spicer; M W Cocalis; J W Moore
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

Review 2.  The Fontan procedure: analysis of cohorts and late complications.

Authors:  R M Freedom; R Hamilton; S J Yoo; H Mikailian; L Benson; B McCrindle; H Justino; W G Williams
Journal:  Cardiol Young       Date:  2000-10       Impact factor: 1.093

Review 3.  Additional pulmonary blood flow has no adverse effect on outcome after bidirectional cavopulmonary anastomosis.

Authors:  Pascal A Berdat; Emré Belli; François Lacour-Gayet; Claude Planché; Alain Serraf
Journal:  Ann Thorac Surg       Date:  2005-01       Impact factor: 4.330

4.  Diastolic ventricular function after the Fontan operation.

Authors:  D J Penny; A N Redington
Journal:  Am J Cardiol       Date:  1992-04-01       Impact factor: 2.778

5.  The partial cavo-pulmonary circulation with an additional source of pulmonary flow. An alternative to the total cavo-pulmonary circulation in patients with a functionally single ventricle.

Authors:  Daniel Sidi
Journal:  Cardiol Young       Date:  2004       Impact factor: 1.093

6.  Abnormal cardiac signs after Fontan type of operation: indicators of residua and sequelae.

Authors:  M P Leung; L N Benson; J F Smallhorn; W G Williams; G A Trusler; R M Freedom
Journal:  Br Heart J       Date:  1989-01

7.  Childhood systemic-pulmonary shunts: subsequent suitability for Fontan operation.

Authors:  M Mietus-Snyder; P Lang; J E Mayer; R A Jones; A R Castaneda; J E Lock
Journal:  Circulation       Date:  1987-09       Impact factor: 29.690

8.  What factors affect ventricular performance after a Fontan-type operation?

Authors:  H Uemura; T Yagihara; Y Kawashima; F Yamamoto; K Nishigaki; O Matsuki; K Okada; T Kamiya; R H Anderson
Journal:  J Thorac Cardiovasc Surg       Date:  1995-08       Impact factor: 5.209

9.  Surgical reinterventions after modified Fontan operations.

Authors:  V P Podzolkov; S B Zaetz; B G Alekyan; M R Chiaureli; I A Yurlov; I G Chernikh
Journal:  Ann Thorac Surg       Date:  1995-12       Impact factor: 4.330

10.  Physiological rationale for a bidirectional cavopulmonary shunt. A versatile complement to the Fontan principle.

Authors:  R A Hopkins; B E Armstrong; G A Serwer; R J Peterson; H N Oldham
Journal:  J Thorac Cardiovasc Surg       Date:  1985-09       Impact factor: 5.209

  10 in total
  4 in total

1.  Author's reply.

Authors:  Mustafa Gülgün; Tevfik Karagöz
Journal:  Anatol J Cardiol       Date:  2015-02       Impact factor: 1.596

2.  Transcatheter closure of antegrade pulmonary blood flow with Amplatzer septal occluder after Fontan operation.

Authors:  Alper Güzeltaş; İbrahim Cansaran Tanıdır; Murat Saygı
Journal:  Anatol J Cardiol       Date:  2015-01-21       Impact factor: 1.596

3.  Transcatheter occlusion of antegrade pulmonary blood flow in children with univentricular heart.

Authors:  Gülhan Tunca Şahin; İbrahim Cansaran Tanıdır; Selman Gökalp; Alper Güzeltaş
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2019-06-19       Impact factor: 0.332

4.  Late recognition and transcatheter closure of ventriculopulmonary artery shunts in Fontan patients.

Authors:  Mohamed Kasem; Jamie Bentham; Grazia Delle Donne; Antigoni Deri; Tomasso Generali; John Thomson
Journal:  Anatol J Cardiol       Date:  2019-11       Impact factor: 1.596

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.